Analyst firms · BofA Securities · CAH
BofA Securities CAH price target and rating history
Cardinal Health Inc. (CAH) · Health Care
BofA Securities rates Cardinal Health Inc. (CAH) Buy with a $145 price target, as of its latest action on Jan 6, 2025. It has published 3 rating actions on CAH since August 2021, including 2 upgrades and 1 downgrade.
- Current rating
- Buy
- Price target
- $145
- Median target, all firms
- Too few
- Actions on CAH
- 3
BofA Securities price target on CAH
Every BofA Securities rating on CAH
- Jan 6, 2025
- Nov 4, 2022
- Aug 5, 2021
How other firms rate CAH
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| RBC Capital Markets | Outperform | $276 | Aug 19, 2026 |
| William Blair | Outperform | Apr 28, 2026 | |
| Citigroup | Buy | Jan 9, 2026 | |
| Barclays | Overweight | $243 | Dec 9, 2025 |
Questions about BofA Securities and CAH
- What is BofA Securities's price target for CAH?
- BofA Securities's latest stated price target for Cardinal Health Inc. (CAH) is $145, from its action on Jan 6, 2025.
- What is BofA Securities's rating on CAH?
- BofA Securities rates CAH Buy, a bullish rating, as of Jan 6, 2025.
- When did BofA Securities last change its view on CAH?
- On Jan 6, 2025, BofA Securities upgrades to Buy from Neutral, price target $132 to $145.
More CAH rating histories
All BofA Securities ratingsCAH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.